Funded Startups in Belfast
Across the 50 most recent funded entries for Belfast, the largest disclosed round is Fibrus’ $289M debt financing on 2022-03-31, which dwarfs the rest of t…
Across the 50 most recent funded entries for Belfast, the largest disclosed round is Fibrus’ $289M debt financing on 2022-03-31, which dwarfs the rest of the disclosed amounts (the next-highest disclosed figures in the table are $27M for Selazar on 2021-11-03 and $23M for Cloudsmith on 2025-03-03). At the other end, the smallest disclosed amount is $10K for Food Safe System (grant) on 2022-08-01, creating a very wide disclosed range.
Timing clusters show up alongside this scale difference: the list spans 2020-06-02 (Re-Vana Therapeutics) through 2026-06-30 (Saltroad). Disclosed-round dates are concentrated in 2026 and 2025 (e.g., Seed/large-ticket rounds like Saltroad’s $2M on 2026-06-30 and Eolas Medical’s $12M on 2026-01-20 sit near multiple 2025 rounds such as Cloudsmith’s $23M on 2025-03-03), while stages and sectors are mixed—five companies carry “Series Unknown” and five carry “undisclosed” round amounts, and Biotechnology, AI, and Data & Analytics each appear in 3+ entries.
Most recent rounds
50 shownRelated listings
Frequently asked
What outlier stands out by disclosed round size, and what does it imply for diligence?
Fibrus’ $289M debt financing on 2022-03-31 is an extreme outlier versus all other disclosed rounds in the table; the next-largest disclosed entries are far lower (e.g., Selazar’s $27M on 2021-11-03 and Cloudsmith’s $23M on 2025-03-03). Any screening by “largest rounds” here should treat Fibrus as the dominant case rather than representative of the rest of Belfast funding.
How concentrated are the most recent rounds in time, based on the 50-row window?
The rows cover 2020-06-02 through 2026-06-30, with multiple entries clustered in 2026 (Saltroad on 2026-06-30, Neurovalens on 2026-05-26, and Causeway Sensors on 2026-04-23 among others). That makes the most recent portion of the table denser than the earlier years, where entries include Re-Vana Therapeutics (2020-06-02) and B-Secur (2020-09-15).
Which sectors are most over-represented relative to the rest of the list?
Data shows at least three recurring sector groupings: Biotechnology appears in multiple rows (e.g., Neurovalens 2026-05-26, Causeway Sensors 2026-04-23, and Angoka 2022-11-08), AI appears multiple times (PulseAI 2026-01-12, AMPLY Discovery 2025-05-01, and Sonrai Analytics 2022-11-10), and Data & Analytics also repeats (Saltroad 2026-06-30, Eolas Medical 2026-01-20, and Nuada 2023-07-27). These clusters suggest sector-specific investor attention rather than purely one-off deals.
Are there many rounds with missing or undisclosed economics that could distort comparisons?
Yes: there are 5 entries marked “undisclosed” (e.g., Neurovalens on 2026-05-26 and PulseAI on 2026-01-12) and 5 entries labeled “Series Unknown” (e.g., Mantis Live on 2025-11-25 and Pitchbooking on 2025-11-03). That means any analysis of stage progression or average deal size for Belfast should rely primarily on the disclosed $ amounts and treat those categories separately.
Within the last 90 days of the most recent round date, what does the mix look like?
Using the latest date in the table (Saltroad on 2026-06-30), the immediately preceding entries include Causeway Sensors ($670K on 2026-04-23), Foresight ($670K on 2026-03-02), and Eolas Medical ($12M on 2026-01-20), alongside at least one “undisclosed” round (Neurovalens on 2026-05-26). The disclosed deals in this window span from $670K up to $12M, with a mix of Data & Analytics and biotech-heavy entries.
How extreme is the smallest disclosed round compared with the rest, and where does it sit in the calendar?
The smallest disclosed amount is $10K for the Food Safe System grant on 2022-08-01. Relative to disclosed deals around it (for example, VascVersa at $600K on 2022-08-08 and Kairos Sports Tech at $610K on 2022-06-28), the $10K figure is a low-end outlier that likely reflects non-standard financing size (grant vs. equity-like rounds).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.